𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of DNA flow cytometry in borderline malignant ovarian tumors

✍ Scribed by Chyong-Huey Lai; Swei Hsueh; Ting-Chang Chang; Chih-Jen Tseng; Kuan-Gen Huang; Hung-Hsueh Chou; Shiow-Meei Chen


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
923 KB
Volume
78
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


BACKGROUND.

The role of flow cytometric DNA analysis in predicting prognosis of patients with borderline malignant ovarian tumors has been controversial.

METHODS.

Fifty cases of patients with borderline malignant ovarian tumors were analyzed by histology and by flow cytometry on paraffin embedded tissue. Multiple tissue blocks and serial sections were analyzed for each tumor. The results of DNA analysis were correlated to clinicopathologic data.


πŸ“œ SIMILAR VOLUMES


Role of immunocytochemistry and DNA flow
✍ Urmil Brahmi; Arvind Rajwanshi; Kusum Joshi; Nirmal Kumar Ganguly; Harpreet Vohr πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 264 KB πŸ‘ 2 views

## Abstract In the present study, DNA flow cytometry (FCM) and immunocytochemistry (ICC) with a selected panel of antibodies were performed on 51 cases of malignant tumors which were referred for fine‐needle aspiration biopsy (FNAB) to our Department of Cytology for the last 2 yr. Twelve cases were

Expression of human telomerase subunits
✍ Satoru Kyo,; Taro Kanaya; Masahiro Takakura; Masaaki Tanaka; Atsuko Yamashita; H πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 105 KB πŸ‘ 2 views

Telomerase activity is involved in the maintenance of telomere length and is thought to be required for cellular immortality and oncogenesis. Three major subunits composing telomerase, human telomerase RNA (hTR), telomeraseassociated protein (TP1) and human telomerase catalytic subunit (hTERT), have

Ploidy assessment of benign and malignan
✍ Ole-Erik Iversen; Elsa Skaarland πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 562 KB

In a prospective study, 112 fresh ovarian tumor samples were collected from 83 consecutive patients. Cellular DNA content was measured by flow cytometry. All the benign (n = 24) and semimalignant (n = 6) tumors were diploid. Of 50 malignant tumors, 24 (48%) were diploid and 26 (52%) were aneuploid.